Regulation of IgE and cytokine production by cAMP: Implications for extrinsic asthma

Clinical Immunology and Immunopathology

Volumn 81, Issue 2, 1996, Pages 101-113

  Fedyk, Eric R ^a   Adawi, Adnan ^a   Looney, R John ^a   Phipps, Richard P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLHISTAMINE; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUTOXAMINE; CHLORPHENIRAMINE; CIMETIDINE; CORTICOSTEROID; CYCLIC AMP; CYTOKINE; DIMAPRIT; FENOTEROL; FORMOTEROL; HISTAMINE; IMMUNOGLOBULIN E; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; ORCIPRENALINE; PHOSPHODIESTERASE INHIBITOR; PROPRANOLOL; PROSTAGLANDIN E1; PROSTAGLANDIN E2; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE;

ASTHMA; PRIORITY JOURNAL; REVIEW;

EID: 0030296547     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0165     Document Type: Review

References (112)

1. 1. Lorenz, M., Jung, S., and Radbruch, A., Switch transcripts in immunoglobulin class switching. Science 267, 1825-1828, 1995.
2. 2. de Vries, J., Atopic allergy and other hypersensitivities. Curr. Opin. Immunol. 6, 835-837, 1994.
3. 3. Smith, W. L., Meade, E. A., and DeWitt, D. L., Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann. NY Acad. Sci. 714, 136-142, 1994.
4. 4. Dupuy, P., Bagot, M., Michel, L., Descourt, B., and Dubertret, L., Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. J. Invest. Dermatol. 96, 408-413, 1991.
5. 5. Ruzika, T., and Aubock, J., Arachidonic acid metabolism in guinea pig Langerhans cells: Studies on cyclooxygenase and lipoxygenase pathways. Adv. Prostaglandin, Thromboxane, Leukotriene Res. 17, 657-663, 1987.
6. 6. Phipps, R. P., Stein, S. H., and Roper, R. L., A new view of prostaglandin E regulation of the immune response. Immunol. Today 12, 349-352, 1991.
7. 7. Brown, D. M., and Phipps, R. P., Characterization and regulation of prostaglandin E2 receptors on normal and malignant murine B lymphocytes. Cell. Immunol. 161, 79-87, 1995.
8. 8. Burchiel, S. W., Hanson, K., and Warner, N. L., Clonal heterogeneity of cyclic AMP responsiveness: A comparison of malignant murine lymphoid cell lines. Int. J. Immunopharmacol. 6, 35-42, 1984.
9. 9. Dailey, M. O., Schreurs, J., and Schulman, H., Hormone receptors on cloned T lymphocytes. Increased responsiveness to histamine, prostaglandins, and beta-adrenergic agents as a late stage event in T cell activation. J. Immunol. 140, 2931-2936, 1988.
10. 10. Paietta, E., and Schwarzmeier, J. D., Differences in beta-adrenergic receptor density and adenylate cyclase activity between normal and leukaemic leukocytes. Eur. J. Clin. Invest. 13, 339-346, 1983.
11. 4. Mol. Immunol. 33, 33-45, 1995.
12. 12. Roper, R. L., and Phipps, R. P., Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis. J. Immunol. 149, 2984-2991, 1992.
13. 13. Roper, R. L., Brown, D. M., and Phipps, R. P., Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE. J. Immunol. 154, 162-170, 1995.
14. 14. Roper, R. L., Conrad, D. H., Brown, D. M., Warner, G. L., and Phipps, R. P., Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis. J. Immunol. 145, 2644-2651, 1990.
15. 2. Immunomethods 2, 261-272, 1993.
16. 16. Ohmori, H., Hikida, M., and Takai, T., Prostaglandin E2 as a selective stimulator of antigen-specific IgE response in murine lymphocytes. Eur. J. Immunol. 20, 2499-2503, 1990.
17. 17. Hikida, M., Takai, T., and Ohmori, H., Selective regulation of antigen-specific IgE response by cyclic AMP level in murine lymphocytes. Immunol Lett. 33, 301-306, 1992.
18. 18. Byron, K. A., Liberates, S., Varigos, G. A., and Wootton, A. M., Interferon-gamma production in atopic dermatitis: a role for prostaglandins? Int. Arch. Allergy Immunol. 99, 50-55, 1992.
19. 19. Pene, J., Rousset, F., Briere, F., Chretien, I., Bonnefoy, J. Y., Spits, H., Yokota, T., Arai, N., Arai, K., Banchereau, J., and de Vries, J. E., IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl. Acad. Sci. USA 85, 6880-6884, 1988.
20. 20. Paul-Eugene, N., Pene, J., Bousquet, J., and Dugas, B., Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4. Cytokine 7, 64-9, 1995.
21. 2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen. J. Immunol. 152, 4282-4290, 1994.
22. 22. O'Garra, A., and Murphy, K., Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6, 458-466, 1994.
23. 23. van der Pouw-Kraan, T. C. T. M., Boeije, C. M., Smeenk, R. J. T., Wijdenes, J., and Aarden, L. A., Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181, 775-779, 1995.
24. 24. Kambayashi, T., Alexander, H. R., Fong, M., and Strassmann, G., Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-104. J. Immunol. 154, 3383-90, 1995.
25. 25. Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M., and Kambayashi, T., Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180, 2365-2370, 1994.
26. 26. Novak, T. J., and Rothenberg, E. V., cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87, 9353-9357, 1990.
27. 27. Hilkens, C. M., Vermeulen, H., van Neerven, R. J., Snijdewint, F. G., Wierenga, E. A., and Kapsenberg, M. L., Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur. J. Immunol. 25(1), 59-63, 1995.
28. 2 inhibits production of Th1 lymphokines, but not of Th2 lymphokines. J. Immunol. 146, 108-113, 1991.
29. 29. Gajewski, T. F., Schell, S. R., and Fitch, F. W., Evidence implicating utilization of different T cell receptor-associated signaling pathways by Th1 and Th2 clones. J. Immunol. 144, 4110-4120, 1990.
30. 30. Munoz, E., Zubiaga, A. M., Merrow, M., Sauter, M. P., and Huber, B., Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation. J. Exp. Med. 172, 95-103, 1990.
31. 31. Watanabe, S., Yssel, H., Harada, Y., and Arai, K. Effects of prostaglandin E2 on Th0-type human T cell clones: Modulation of functions of nuclear proteins involved in cytokine production. Int. Immunol. 6, 523-532, 1994.
32. 32. Waldmann, T. A., Bull, J. M., Bruce, R. M., Broder, S., Jost, M. C., Balestra, S. T., and Suer, M. E., Serum immunoglobulin E levels in patients with neoplastic disease. J. Immunol. 113, 379-386, 1974.
33. 33. Leung, D. Y. M., Key, L., Steinberg, J. J., Young, M. C., Von-Deck, M., Wilkinson, R., and Geha, R. S., Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J. Immunol. 140, 84-88, 1988.
34. 34. Cohen-Solal, M., Prieur, A. M., Prin, L., Denne, M. A., Launay, J. M., Graulet, A. M., Brazier, M., Griscelli, C., and de Vernejoul, M. C., Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome. Clin. Immunol. Immunopathol. 76, 75-81, 1995.
35. 35. Ringden, O., Persson, U., Johansson, S. G. O., Wilczek, H., Gahrton, G., Lundgren, G., Lonnqvist, B., and Moller, E., Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood 61,1190-1195, 1993.
36. 36. Sarayan, J. A., Rappeport, J., Leung, D. Y. M., Parkman, R., and Geha, R. S., Regulation of human IgE synthesis in acute graft versus host disease. J. Clin. Invest. 71, 556-564, 1983.
37. 37. Romagnani, S., Regulation of the development of type 2 T-helper cells in allergy. Curr. Opin. Immunol. 6, 838-846, 1994.
38. 38. Jacob, T., Huspith, B. N., Latchman, Y. E., Rycroft, R., and Brostoff, J., Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin. Exp. Immunol. 79, 380-384, 1990.
39. 39. Chan, S. C., Kim, J. W., Henderson, W. R., and Hanifin, J. F., Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J. Immunol. 151, 3345-3352, 1993.
40. 40. Hallek, M., Kamp, T., Haen, E., Gohly, U., Emmerich, B., and Remien, J., Reduced responsiveness of adenylate cyclase to forskolin in human lymphoma cells. Biochem. Pharmacol. 42, 1329-1334, 1991.
41. 41. Lycke, N., and Strober, W., Cholera toxin promotes B cell isotype differentiation. J. Immunol. 142, 3781-3787, 1989.
42. 42. Lycke, N., Severinson, E., and Strober, W., Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation. J. Immunol. 145, 3316-3324, 1990.
43. 43. Snider, D. P., Marshall, J. S., Perdue, M. H., and Liang, H., Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 153, 647-657, 1994.
44. 44. Tamura, S., Shoji, Y., Hasiguchi, K, Aizawa, C., and Kurata, T., Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. Vaccine 12, 1238-1240, 1994.
45. 45. McGhee, J. R., Xu-Amano, J., Miller, C. J., Jackson, R. J., Fujihashi, K., and Staats, H. F., The common mucosal immune system: From basic principles to enteric vaccines with relevance for the female reproductive tract. Reprod. Fertil. Dev. 6, 369-679, 1994.
46. 46. Xu-Amano, J., Kiyono, H., Jackson, R. J., Staats, H. F., Fujihashi, K, Burrows, P. D., Elson, C. O., Pillai, S., and McGhee, J. R., Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178, 1309-1320, 1993.
47. 47. Wilson, A. D., Bailey, M., Williams, N. A., and Stokes, C. R., The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur. J. Immunol. 21, 2333-2339, 1991.
48. 48. Shah, T. P., Lichtenstein, L. M., Undem, B., and MacDonald, S. M., Effects of cyclic-AMP on human IgE synthesis in vitro. J. Allergy Clin. Immunol. 89, 173, 1992. [Abstract 115]
49. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150, 5321-5329, 1993.
50. 50. Rott, O., and Cash, E., Fleischer, B., Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol. 23(8), 1745-1751, 1993.
51. 51. Hill, S. J., Multiple histamine receptors: Properties and functional characteristics. Biochem. Soc. Trans. 20, 122-125, 1992.
52. 52. Khan, M. M., Melmon, K. L., Fathman, C. G., Hertel-Wulff, B., and Strober, S., The effects of autacoids on cloned murine lymphoid cells: Modulation of IL 2 secretion and the activity of natural suppressor cells. J. Immunol. 134, 4100-4106, 1985.
53. 53. Khan, M. M., Sansoni, P., Engleman, E. G., and Melmon, K. L., Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells. J. Clin. Invest. 75, 1578-1583, 1985.
54. 54. Melmon, K. L., Bourne, H. R., Weinstein, Y., Shearer, G. M., Kram, J., and Bauminger, S., Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. J. Clin. Invest. 53, 13-21, 1974.
55. 55. Melmon, K. L., Rocklin, R. E., and Rosenkranz, R. P., Autacoids as modulators of the inflammatory and immune response. Am. J. Med. 71, 100-106, 1981.
56. 56. Fujimoto, M., and Kimata, H., Histamine inhibits immunoglobulin production via histamine H2 receptors without affecting cell growth in human B cells. Clin. Immunol. Immunopathol. 73, 96-102, 1994.
57. 57. Hebert, J., Beaudoin, R., Girard, M., Beaulieu, A., Perlmutter, L., and Tremblay, C., The regulatory effect of histamine on the immune response. III. Defect on in vitro IgE production in atopics. Ann. Allergy 53, 138-142, 1984.
58. 58. Levo, Y., Harbeck, R. J., and Kirkpatrick, C. H., The regulatory effect of histamine on the in vitro synthesis of IgE. Allergy 41, 26-29, 1986.
59. 59. Carlsson, R., Dohlsten, M., and Sjogren, H. O., Histamine modulates the production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cells. Cell. Immunol. 96, 104-112, 1985.
60. 60. Huchet, R., and Grandjon, D., Histamine-induced regulation of IL-2 synthesis in man: Characterization of two pathways of inhibition. Ann. Inst. Pasteur 139, 485-499, 1988.
61. 61. Dohlsten, M., Hedlund, G., Sjogren, H. O., and Carlsson, R., Inhibitory effects of histamine on interleukin 2 and gamma interferon production of different human T helper cell subsets. Scand. J. Immunol. 28, 727-733, 1988.
62. 62. Schmidt, J., Fleissner, S., Heimann-Weitschat, I., Lindstaedt, R., and Szelenyi, I., Histamine increases anti-CD3 induced IL-5 production of TH2-type T cells via histamine H2-receptors. Agents Actions 42, 81-85, 1994.
63. 63. Pochet, R., Delespesse, G., Gausset, P. W., and Collet, H., Distribution of beta-adrenergic receptors on human lymphocyte subpopulations. Clin. Exp. Immunol. 38, 578-584, 1979.
64. 64. Landmann, R. M., Burgisser, E., Wesp, M., and Buhler, F. R., Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes. J. Recept. Res. 4, 37-50, 1984.
65. 65. Feldman, R. D., Hunninghake, G. W., and McArdle, W. L., Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J. Immunol. 139, 3355-3359, 1987.
66. 66. Butchers, P. R., Vardey, C. J., and Johnson, M., Salmeterol: A potent and long-acting inhibitor of inflammatory mediator release from human lung. Br. J. Pharmacol. 104, 672-676, 1991.
67. 67. Coqueret, O., Lagente, V., Frere, C. P., Braquet, P., and Mencia-Huerta, J. M., Regulation of IgE production by beta 2-adrenoceptor agonists. Ann. NY Acad. Sci. 725, 44-49, 1994.
68. 68. Paul-Eugene, N., Pene, J., Bousquet, J., and Dugas, B., Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4. Cytokine 7, 64-69, 1995.
69. 69. Paul-Eugene, N., Kolb, J. P., Calenda, A., Gordon, J., Kikutani, H., Kishimoto, T., Mencia-Huerta, J. M., Braquet, P., and Dugas, B., Functional interaction between beta 2-adrenoceptor agonists and interleukin-4 in the regulation of CD23 expression and release and IgE production in human. Mol. Immunol. 30, 157-164, 1993.
70. 70. Burd, P. R., Role of cytokines in mast cell function. In "Human Cytokines" (R. S. Aggarwal and D. K. Puri, Eds.), pp. 87-99. Blackwell, New York, 1995.
71. 71. Gauchat, J. F., Henchoz, S., Mazzei, G., Aubry, J. P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores-Romo, L., and Thompson, J., Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340-343, 1993.
72. 72. Hu, Z., Asano, K, Seki, H., and Shimamura, T., An essential role of prostaglandin E on mouse mast cell induction. J. Immunol. 155, 2134-2142, 1995.
73. 73. Coffey, R. G., Effects of cyclic nucleotides on granulocytes. Immunol. Sem. 1992.
74. 74. Peachell, P. T., MacGlashan, D. W., Jr., Lichtenstein, L. M., and Schleimer, R. P., Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J. Immunol. 140, 571-579, 1988.
75. 75. Hahn, S., and Moroni, C., Modulation of cytokine expression in PB-3c mastocytes by IBMX and PMA. Lymphokine Cytokine Res. 13, 247-252, 1994.
76. 76. Bochner, B. S., Undem, B. J., and Lichtenstein, L. M., Immunological aspects of allergic asthma. Ann. Rev. Immunol. 12, 295-335, 1994.
77. 77. Barnes, P. J., Beta adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 152, 838-860, 1995.
78. 78. Busse, W. W., Coffman, R. L., Gelfand, E. W., Kay, A. B., and Rosenwasser, L. J., Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. Am. J. Respir. Crit. Care Med. 152, 388-393, 1995.
79. 79. Robinson, D., Hamid, Q., Ying, S., Bentley, A., Assoufi, B., Durham, S., and Kay, A. B., Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am. Rev. Respir. Dis. 148, 401-406, 1993.
80. 80. Nakajima, H., Iwamoto, L, Tomoe, S., Matsumura, R., Tomioka, H., Takatsu, K, and Yoshida, S., CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146, 374-377, 1992.
81. 81. Hitoshi, Y., Yamaguchi, N., Korenaga, M., Mita, S., Tominaga, A., and Takatsu, K., In vivo administration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic mice. Int. Immunol 3, 135-139, 1991.
82. 82. Iwama, T., Nagai, H., Suda, H., Tsuruoka, N., and Koda, A., Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways. Br. J. Pharmacol. 105,19-22, 1992.
83. 83. Ying, S., Durham, S. R., Corrigan, C. J., Hamid, Q., and Kay, A. B., Phenotype of cells expressing mRNA for TH2-type (inter leukin 4 and interleukin 5) and THl-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12, 477-487, 1995.
84. 84. Bentley, A. M., Meng, Q., Robinson, D. S., Hamid, Q., Kay, A. B., and Durham, S. R., Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8, 35-42, 1993.
85. 85. Ohnishi, T., Kita, H., Weiler, D., Sur, S., Sedgwick, J. B., Calhoun, W. J., Busse, W. W., Abrams, J. S., and Gleich, G. J., IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147, 901-907, 1993.
86. 86. Hamid, Q., Azzawi, M., Ying, S., Moqbel, R., Wardlaw, A. J., Corrigan, C. J., Bradley, B., Durham, S. R., Collins, J. V., and Jeffery, P. K, Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects. Int. Arch. Allergy Appl. Immunol. 94, 169-170, 1991.
87. 87. Corrigan, C. J., Hamid, Q., North, J., Barkans, J., Moqbel, R., Durham, S., Gemou-Engesaeth, V., and Kay, A. B., Peripheral blood CD4 but not CDS t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: Effect of glucocorticoid therapy. Am. J. Respir. Cell Mol. Biol. 12, 567-578, 1995.
88. 88. Filley, W. V., Holley, K. E., Hephart, G. M., and Gleich, G. J., Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 2(8288), 11-16, 1982.
89. 89. Pin, I., Radford, S., Kolendowicz, R., Jennings, B., Denburg, J. A., Hargreave, F. E., and Dolovich, J., Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur. Respir. J. 6, 1249-1256, 1993.
90. 90. Sedgwick, J. B., Calhoun, W. J., Gleich, G. J., Kita, H., Abrams, J. S., Schwartz, L. B., Volovitz, B., Ben-Yaakov, M., and Busse, W. W., Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am. Rev. Respir. Dis. 144, 1274-1281, 1991.
91. 91. Sempowski, G. D., Beckmann, M. P., Derdak, S., and Phipps, R. P., Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J. Immunol. 152, 3606-3614, 1994.
92. 92. Rossing, T. H., Methylxanthines in 1989. Ann. Intern. Med. 100, 502-504, 1989.
93. 93. Nelson, H. S., Beta-adrenergic bronchodilators. N. Engl. J. Med. 333, 499-506, 1995.
94. 94. Verberne, A. A., and Kerrebijn, K. F., Effects of beta 2-receptor agonists on airway responsiveness. Life Sci. 52, 2181-2191, 1993.
95. 95. De Monchy, J. G., Kauffman, H. F., Venge, P., Koeter, G. H., Jansen, H. M., Sluiter, H. J., and De Vries, K., Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Resp. Dis. 131, 373-376, 1985.
96. 96. Wahedna, I., Wong, C. S., Wisniewski, A. F., Pavord, I. D., and Tattersfield, A. E., Asthma control during and after cessation of regular beta 2-agonist treatment. Am. Rev. Respir. Dis. 148, 707-712, 1993.
97. 97. Cockcroft, D. W., McParland, C. P., Britto, S. A., Swystun, V. A., and Rutherford, B. C., Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342(8875), 833-837, 1993.
98. 98. van Schayck, C. P., Graafsma, S. J., Visch, M. B., Dompeling, E., van Weel, C., and van Herwaarden, C. L., Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J. Allergy Clin. Immunol. 86, 793-800, 1990.
99. 99. Skorodin, M. S., Beta-adrenergic agonists. A problem. Chest 103, 1587-1590, 1993.
100. 100. Van Metre, T. E., Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticus. J. Allergy 43, 101-113, 1969.
101. 101. Keighley, J. F., Iatrogenic asthma associated with adrenergic aerosols. Ann. Int. Med. 65, 985-995, 1966.
102. 102. Trautlein, J., Allegra, J., Field, J., and Gillin, M., Paradoxic bronchospasm after inhalation of isoproterenol. Chest 70, 711-714, 1976.
103. 103. Branscomb, B. V., Efficacy and side effects of fenoterol compared with isoproterenol administered by metered dose inhalers in asthma. Chest 73, 1002-1003, 1978.
104. 104. Trembath, P. W., Greenacre, J. K., Anderson, M., Dimmock, S., Mansfield, L., Wadsworth, J., and Green, M., Comparison of four weeks' treatment with fenoterol and terbutaline aerosols in adult asthmatics. A double-blind crossover study. J. Allergy Clin. Immunol. 63, 395-400, 1979.
105. 105. Repsher, L. H., Anderson, J. A., Bush, R. K., Falliers, C. J., Kass, I., Kemp, J. P., Reed, C., Siegel, S., and Webb, D. R., Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol. Chest 85, 34-38, 1984.
106. 106. Storms, W. W., Bodman, S. F., Nathan, R. A., Busse, W. W., Bush, R. K., Falliers, C. J., O'Hollaren, J. D., and Weg, J. G., Use of ipratropium bromide in asthma. Results of a multi-clinic study. Am. J. Med. 81, 61-66, 1986.
107. 107. Pearce, N., Beasley, R., Crane, J., Burgess, C., and Jackson, R., End of the New Zealand asthma mortality epidemic. Lancet 345(8941), 41-44, 1995.
108. 108. Page, C. P., Beta agonists and the asthma paradox. J. Asthma 30, 155-164, 1993.
109. 109. Chung, K. F., The current debate concerning beta-agonists in asthma: A review. J. R. Soc. Med. 86, 96-100, 1993.
110. 110. Corrigan, C. J., Hamid, Q., North, J., Barkans, J., Moqbel, R., Durham, S., Gemou-Engesaeth, V., and Kay, A. B., Peripheral blood CD4 but not CDS t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: Effect of glucocorticoid therapy. Am. J. Respir. Cell Mol. Biol. 12, 567-578, 1995.
111. 111. Bradding, P., Feather, I. H., Wilson, S., Holgate, S. T., and Howarth, P. H., Cytokine immunoreactivity in seasonal rhinitis: Regulation by a topical corticosteroid. Am. J. Respir. Crit. Care Med. 151, 1900-1906, 1995.
112. 112. Lamas, A. M., Leon, O. G., and Schleimer, R. P., Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colonystimulating factor. J. Immunol. 147, 254-259, 1991.